z-logo
open-access-imgOpen Access
Identification of High‐Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function
Author(s) -
Cicoira Mariantonietta,
Rossi Andrea,
Chiampan Andrea,
Frigo Giulia,
Bergamini Corinna,
Rigolli Marzia,
Zanolla Luisa,
Vassanelli Corrado
Publication year - 2012
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.22024
Subject(s) - medicine , ejection fraction , heart failure , cardiology , hazard ratio , proportional hazards model , confidence interval , etiology
Background: Left ventricular (LV) dysfunction and remodeling are key pathophysiological features underlying disease progression in chronic heart failure (CHF). Hypothesis: To describe the course of LV dysfunction and identify predictors and prognostic impact of changes in LV volumes and function in stable CHF patients under optimal therapy. Methods: There were 318 consecutive CHF outpatients who underwent a repeated echocardiographic evaluation at baseline and at 1 year and subsequently followed‐up for at least 12 months. The end point of the study was all‐cause mortality. Results: Mean LV ejection fraction (LVEF) was 33 ± 7% at baseline and 36 ± 9% at follow‐up. Twenty‐four percent of patients had an improvement of LVEF >5 absolute points (group 1); 58% remained stable (group 2), 17% worsened at >5 absolute points (group 3). Age, New York Heart Association class, diuretic dose, renal function, and baseline LVEF were independent predictors of LVEF improvement at 1 year. At the Cox analysis, patients in group 3 had a 4‐fold higher risk of death when compared with group 1 (hazard ratio: 3.99, 95% confidence interval: 1.6‐9.9, P = 0.002), independently of age, etiology, and symptoms severity. Conclusions: In stable CHF outpatients, LV function improves in 24% of cases; a modest decrease in LV systolic function is associated with a significantly higher risk of all‐cause mortality, independent of other markers of disease severity. Clin. Cardiol. 2012 doi: 10.1002/clc.22024 The authors have no funding, financial relationships, or conflicts of interest to disclose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here